Dual-targeting prodrug nanotheranostics for NIR-Ⅱ fluorescence imaging-guided photo-immunotherapy of glioblastoma

Glioblastoma (GBM) therapy is severely impaired by the blood–brain barrier (BBB) and invasive tumor growth in the central nervous system. To improve GBM therapy, we herein presented a dual-targeting nanotheranostic for second near-infrared (NIR-II) fluorescence imaging-guided photo-immunotherapy. Fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Fenglin, Lai, Yi, Ye, Jiayi, Saeed, Madiha, Dang, Yijing, Zou, Zhifeng, Chen, Fangmin, Zhang, Wen, Xu, Zhiai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513488/
https://www.ncbi.nlm.nih.gov/pubmed/36176914
http://dx.doi.org/10.1016/j.apsb.2022.05.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513488/
https://www.ncbi.nlm.nih.gov/pubmed/36176914
http://dx.doi.org/10.1016/j.apsb.2022.05.016

Ejemplares similares